These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15922632)

  • 1. Additive effects of ziprasidone and D,L-sotalol on the action potential in rabbit Purkinje fibres and on the hERG potassium current.
    Ducroq J; Printemps R; Le Grand M
    J Pharmacol Toxicol Methods; 2005; 52(1):115-22. PubMed ID: 15922632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action potential experiments complete hERG assay and QT-interval measurements in cardiac preclinical studies.
    Ducroq J; Printemps R; Guilbot S; Gardette J; Salvetat C; Le Grand M
    J Pharmacol Toxicol Methods; 2007; 56(2):159-70. PubMed ID: 17604185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve.
    Vormberge T; Hoffmann M; Himmel H
    J Pharmacol Toxicol Methods; 2006; 54(2):130-40. PubMed ID: 16757186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of the anti-cancer drug lapatinib on cardiac repolarization.
    Lee HA; Kim EJ; Hyun SA; Park SG; Kim KS
    Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):614-8. PubMed ID: 20406211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective block of IKs plays a significant role in MAP triangulation induced by IKr block in isolated rabbit heart.
    Guérard NC; Traebert M; Suter W; Dumotier BM
    J Pharmacol Toxicol Methods; 2008; 58(1):32-40. PubMed ID: 18582585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I(Kr) vs. I(Ks) blockade and arrhythmogenicity in normoxic rabbit Purkinje fibers: does it really make a difference?
    Puddu PE; Legrand JC; Sallé L; Rouet R; Ducroq J
    Fundam Clin Pharmacol; 2011 Jun; 25(3):304-12. PubMed ID: 21241363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choice of cardiac tissue in vitro plays an important role in assessing the risk of drug-induced cardiac arrhythmias in human: beyond QT prolongation.
    Lu HR; Vlaminckx E; Gallacher DJ
    J Pharmacol Toxicol Methods; 2008; 57(1):1-8. PubMed ID: 17964190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Block of hERG channel by ziprasidone: biophysical properties and molecular determinants.
    Su Z; Chen J; Martin RL; McDermott JS; Cox BF; Gopalakrishnan M; Gintant GA
    Biochem Pharmacol; 2006 Jan; 71(3):278-86. PubMed ID: 16325148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suitability of commonly used excipients for electrophysiological in-vitro safety pharmacology assessment of effects on hERG potassium current and on rabbit Purkinje fiber action potential.
    Himmel HM
    J Pharmacol Toxicol Methods; 2007; 56(2):145-58. PubMed ID: 17590357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization.
    Terrar DA; Wilson CM; Graham SG; Bryant SM; Heath BM
    J Pharmacol Toxicol Methods; 2007; 56(2):171-85. PubMed ID: 17596973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block.
    Martin RL; McDermott JS; Salmen HJ; Palmatier J; Cox BF; Gintant GA
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):369-79. PubMed ID: 15076220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct effects of arsenic trioxide on action potentials in isolated cardiac tissues: importance of the choice of species, type of cardiac tissue and perfusion time.
    Lu HR; Vlaminckx E; Cools F; Gallacher DJ
    J Pharmacol Toxicol Methods; 2012 Sep; 66(2):135-44. PubMed ID: 22445855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
    Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
    Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential?
    Carlsson L; Amos GJ; Andersson B; Drews L; Duker G; Wadstedt G
    J Pharmacol Exp Ther; 1997 Jul; 282(1):220-7. PubMed ID: 9223557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle.
    Jost N; Virág L; Bitay M; Takács J; Lengyel C; Biliczki P; Nagy Z; Bogáts G; Lathrop DA; Papp JG; Varró A
    Circulation; 2005 Sep; 112(10):1392-9. PubMed ID: 16129791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential.
    Orvos P; Kohajda Z; Szlovák J; Gazdag P; Árpádffy-Lovas T; Tóth D; Geramipour A; Tálosi L; Jost N; Varró A; Virág L
    Toxicol Sci; 2019 Apr; 168(2):365-380. PubMed ID: 30561737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes.
    Peng S; Lacerda AE; Kirsch GE; Brown AM; Bruening-Wright A
    J Pharmacol Toxicol Methods; 2010; 61(3):277-86. PubMed ID: 20153443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects.
    Schram G; Zhang L; Derakhchan K; Ehrlich JR; Belardinelli L; Nattel S
    Br J Pharmacol; 2004 Aug; 142(8):1300-8. PubMed ID: 15277312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration.
    Hong HK; Lee BH; Park MH; Lee SH; Chu D; Kim WJ; Choe H; Hee Choi B; Jo SH
    Eur J Pharmacol; 2013 Feb; 702(1-3):165-73. PubMed ID: 23395964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of antiarrhythmic agents on post-pause repolarization in cardiac Purkinje fibres.
    Wyse KR; Bursill JA; Campbell TJ
    Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):825-9. PubMed ID: 8911721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.